RingMR, RountreeR. Maximizing impact in integrative medicine: A clinical conversation with Melinda R. Ring, MD, FACP, ABOIM, and Robert Rountree, MD. Alternative Complementary Therapies, 2021; 27:254–261.
2.
United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2024. Online document at: https://usrds-adr.niddk.nih.gov/2024/chronic-kidney-disease/1-ckd-in-the-general-population [Accessed February 6, 2025].
3.
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2020; 395:709–733.
4.
KovesdyCP. Epidemiology of chronic kidney disease: An update 2022. Kidney Int Suppl (2011), 2022; 12:7–11.
5.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int, 2024; 105:S117–S314.
6.
KanchanasurakitS, ArsuA, SiriplabplaW, et al.Acetaminophen use and risk of renal impairment: A systematic review and meta-analysis. Kidney Res Clin Pract, 2020; 39:81–92.
7.
KuoPF, HuangYT, ChuangMH, JiangMY. Association of low-level heavy metal exposure with risk of chronic kidney disease and long-term mortality. PLoS One, 2024; 19:e0315688.
8.
JufarAH, LankadevaYR, MayCN, et al.Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond. Am J Physiol Regul Integr Comp Physiol, 2020; 319:R690–R702.
9.
SuenagaT, TanakaS, KitamuraH, et al.Estimated potassium intake and the progression of chronic kidney disease. Nephrol Dial Transplant, 2024:gfae277.
10.
WalkerAF, MarakisG, MorrisAP, RobinsonPA. Promising hypotensive effect of hawthorn extract: A randomized double-blind pilot study of mild, essential hypertension. Phytother Res, 2002; 16:48–54.
